Unlicensed or unapproved medicines are pharmaceutical products that:
* Are approved in one country but not yet authorized in another
* Are required for named patient, compassionate use, or emergency treatment
* Address rare diseases, critical care, or life-threatening conditions
Our role is not to bypass regulations, but to support lawful and ethical access under permitted international frameworks.
Ikris Pharma International supports global access through recognized mechanisms such as:
* Named Patient Programs (NPP)
* Compassionate use or early access programs
* Emergency and urgent medical supply
* Institutional and hospital-driven requests
Each request is evaluated individually to ensure regulatory alignment and medical justification.
As an international pharmaceutical exporter, we provide:
* Verified sourcing from approved manufacturing facilities
* Product authenticity and batch traceability
* Regulatory documentation and export coordination
* Secure international logistics, including cold chain when required
We act as a logistics and access facilitator, ensuring medicines reach patients responsibly.
We commonly support access to medicines across therapeutic areas such as:
* Oncology and hematology
* Critical care and intensive treatment
* Rare and orphan diseases
* HIV, Hepatitis, and infectious diseases
* Specialized hospital-only therapies
👉 Learn more: Speciality & Life-Saving Medicines Export
Our global access solutions are designed for:
* Hospitals and specialized treatment centers
* Physicians and clinical teams
* NGOs and humanitarian healthcare organizations
* Government health departments and public programs
We understand the sensitivity and urgency involved in these cases and operate with discretion and professionalism.
For each shipment, we assist with:
* Medical justification and request documentation
* Product and batch information
* Export documentation and compliance checks
* Coordination with logistics and customs partners
Our structured process helps reduce delays and compliance risks.
Ikris Pharma International is committed to:
* Ethical medicine access
* Transparency in sourcing and documentation
* Patient safety and product integrity
* Respect for international and local regulations
We do not promote or distribute medicines outside lawful frameworks.
If you require assistance with accessing unlicensed or unapproved medicines, our team can guide you through the process in a compliant and responsible manner.
👉 **Contact us** to discuss your global access requirements.
Looking for a pharmaceutical exporter who understands regulations, ensures authenticity, and delivers with precision? Connect with Ikris Pharma International today.